Gross Tumor Volume Segmentation for Stage III NSCLC Radiotherapy Using 3D ResSE-Unet.

Abstract

Introduction: Radiotherapy is one of the most effective ways to treat lung cancer. Accurately delineating the gross target volume is a key step in the radiotherapy process. In current clinical practice, the target area is still delineated manually by radiologists, which is time-consuming and laborious. However, these problems can be better solved by deep learning-assisted automatic segmentation methods.Methods: In this paper, a 3D CNN model named 3D ResSE-Unet is proposed for gross tumor volume segmentation for stage III NSCLC radiotherapy. This model is based on 3D Unet and combines residual connection and channel attention mechanisms. Three-dimensional convolution operation and encoding-decoding structure are used to mine three-dimensional spatial information of tumors from computed tomography data. Inspired by ResNet and SE-Net, residual connection and channel attention mechanisms are used to improve segmentation performance. A total of 214 patients with stage III NSCLC were collected selectively and 148 cases were randomly selected as the training set, 30 cases as the validation set, and 36 cases as the testing set. The segmentation performance of models was evaluated by the testing set. In addition, the segmentation results of different depths of 3D Unet were analyzed. And the performance of 3D ResSE-Unet was compared with 3D Unet, 3D Res-Unet, and 3D SE-Unet.Results: Compared with other depths, 3D Unet with four downsampling depths is more suitable for our work. Compared with 3D Unet, 3D Res-Unet, and 3D SE-Unet, 3D ResSE-Unet can obtain superior results. Its dice similarity coefficient, 95th-percentile of Hausdorff distance, and average surface distance can reach 0.7367, 21.39mm, 4.962mm, respectively. And the average time cost of 3D ResSE-Unet to segment a patient is only about 10s.Conclusion: The method proposed in this study provides a new tool for GTV auto-segmentation and may be useful for lung cancer radiotherapy.